Skip to content
Article Rich – Lifestyle
Author:
InspireMD Inc.
InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD’s CGuard Prime Carotid Stent Platform
November 17, 2026
InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026
November 16, 2026
InspireMD Announces Pricing of $37.5 Million Public Offering
November 13, 2026
InspireMD Announces Proposed Public Offering
November 12, 2026
InspireMD Reports Third Quarter 2026 Financial Results
November 12, 2026
InspireMD Announces FDA Approval of the CGuard® Prime TransCarotid Stent System for Transcarotid Artery Revascularization (TCAR) Procedures
November 12, 2026
InspireMD Announces Updated Timing for Third Quarter 2026 Financial Results
November 11, 2026
InspireMD to Announce Third Quarter 2026 Financial Results
October 29, 2026
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million
September 21, 2026
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 4, 2026
1
2
Next Page
→